annual report 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.0 pts more than Nifty Microcap 250 and 7.3 pts more than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
CHD Chemicals Limited has filed its Annual Report for FY2024-25 along with the notice for its 12th Annual General Meeting scheduled for September 30, 2025, to be held via video conferencing. Key financials show a sharp deterioration: total revenue fell to Rs. 688.45 lacs from Rs. 1,623.04 lacs in the previous year (a drop of about 58%), and the company slipped into a loss of Rs. 19.64 lacs versus a profit of Rs. 25.81 lacs last year. EBITDA also declined steeply to Rs. 23.44 lacs from Rs. 58.91 lacs. The notice seeks shareholder approval for adopting the audited financials, re-appointing Mrs. Santosh Rani as a director, appointing M/s Neeraj Jindal & Associates as Secretarial Auditors for five years, and appointing two new Independent Directors (Mr. Satyaveer Singh Dangi and Mr. Pawan Kumar Joshi). No changes were made to the authorized or paid-up share capital during the year.
The dramatic revenue decline and swing to a loss signal serious operational weakness for the chemicals trading business in FY25, which is likely to weigh negatively on investor sentiment and the stock price in the short term. The proposed appointment of a new secretarial auditor and two independent directors is routine governance housekeeping with no material impact.